FDA Flags Sexual Enhancement and Energy Products With Hidden Drugs
Agency warns some over-the-counter sexual enhancement and energy products contain undisclosed prescription drugs or other hidden ingredients.
Tag • 4 articles
Therapy Access
Articles currently tagged Therapy Access.
What the iPLEDGE REMS Means for Patients Using High‑Risk Acne Drugs
The FDA’s iPLEDGE Risk Evaluation and Mitigation Strategy aims to reduce the danger of severe birth defects from certain acne medicines.
How Firm Is the iPLEDGE REMS? Assessing the Near-Term Outlook
The FDA’s iPLEDGE REMS is designed to curb embryo‑fetal risk. What is actually known about its status—and how likely is formal confirmation in the coming week?
Torrent Pharmaceuticals Cited by FDA for Adulterated Finished Drugs
U.S. regulators have flagged Torrent Pharmaceuticals Limited for CGMP violations tied to adulterated finished medicines, raising quality and oversight questions.